Search for Clinical Trial Results
Bourneville Syndrome - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Condition: Tuberous Sclerosis Complex-associated Refractory Seizures Date: 2012-10-09 Interventions:
|
Active, not recruiting |
Study Name: Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM Condition:
Date: 2007-06-21 Interventions: Drug: sirolimus daily oral sirolimus with dosage individualised by trough blood levels |
Completed |
Study Name: Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) Condition:
Date: 2010-02-15 Interventions: Drug: Everolimus Everolimus is available in tablet form. The starting dose will be 5 mg/m2/day, rounded |
Completed |
Study Name: Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) Condition:
Interventions: |
Recruiting |
Study Name: Study of Skin Tumors in Tuberous Sclerosis Condition:
Date: 2000-01-20 |
Completed |
Study Name: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Condition:
Date: 2008-11-17 Interventions: Drug: everolimus (RAD001) Subjects will resume the dosing regimen that they were receiving at the comple |
Recruiting |
Study Name: A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) Condition:
Date: 2015-09-07 Interventions:
|
Enrolling by invitation |
Study Name: An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) Condition:
Date: 2015-09-07 Interventions: Drug: GWP42003-P Yellow oily solution containing cannabidiol dissolved in the excipients sesame oil and |
Completed |
Study Name: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Condition:
|
Recruiting |
Study Name: Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex Condition: Date: 2024-05-14 |